Stocks Health care ELAN
NYSE · Health careElanco Animal Health Inc (ELAN)
Elanco Animal Health Inc brought in $5B of revenue over the twelve months to June 30, 2026, up 12.0% from a year earlier. It posted a net loss of $199M. Operating cash flow minus capital spending left $284M of free cash flow in fiscal 2025. At June 30, 2026 it held $530M in cash against $3.7B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
What Elanco Animal Health Inc does
Elanco Animal Health Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker ELAN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $4.7B | -$232M | -$0.47 | $284M |
| 2024 | $4.4B | $338M | $0.68 | $394M |
| 2023 | $4.4B | -$1.2B | -$2.50 | $131M |
| 2022 | $4.4B | -$78M | -$0.16 | $281M |
| 2021 | $4.8B | -$483M | -$0.99 | $324M |
| 2020 | $3.3B | -$574M | -$1.30 | -$176M |
Latest SEC filings
What Elanco Animal Health Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026
- August 5, 2026
- July 14, 2026Passive stake (5% or more) SCHEDULE 13G
- May 27, 2026
- May 27, 2026
- May 14, 2026Passive stake changed SCHEDULE 13G/A
- May 13, 2026Passive stake changed SCHEDULE 13G/A
- May 6, 2026Quarterly report 10-Q · period to March 31, 2026
- May 6, 2026
- April 29, 2026Passive stake (5% or more) SCHEDULE 13G
Questions about ELAN
What does Elanco Animal Health Inc do?
Elanco Animal Health Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker ELAN.
Is Elanco Animal Health Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $199M on revenue of $5B.
How much revenue does Elanco Animal Health Inc make?
Over the twelve months to June 30, 2026 Elanco Animal Health Inc reported revenue of $5B. That is 12.0% more than a year earlier.
When did Elanco Animal Health Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 22, 2026.
Similar companies
Follow ELAN
Get an email when Elanco Animal Health Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow ELAN: get an email when it filesWhere the numbers come from
Financial figures are the values Elanco Animal Health Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.